ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,874,000 | -60.5% | 428,974 | -79.2% | 0.04% | -61.3% |
| Q1 2019 | $50,319,000 | -0.2% | 2,063,959 | -41.7% | 0.11% | -11.9% |
| Q4 2018 | $50,408,000 | +34.0% | 3,537,371 | +43.0% | 0.13% | +59.5% |
| Q3 2018 | $37,605,000 | +24.7% | 2,474,019 | +37.7% | 0.08% | +9.7% |
| Q2 2018 | $30,151,000 | +24.7% | 1,796,839 | +21.3% | 0.07% | +20.0% |
| Q1 2018 | $24,172,000 | +639.2% | 1,481,131 | +479.7% | 0.06% | +650.0% |
| Q4 2017 | $3,270,000 | -6.0% | 255,500 | -9.6% | 0.01% | -20.0% |
| Q3 2017 | $3,477,000 | – | 282,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |